<DOC>
	<DOCNO>NCT00817635</DOCNO>
	<brief_summary>This study assess blood pressure effect , safety tolerability LCI699 compare placebo eplerenone patient resistant hypertension .</brief_summary>
	<brief_title>A Study Evaluate Effects LCI699 Safety Efficacy Subjects With Resistant Hypertension Receiving Combination Therapy With Three More Antihypertensive Drugs , Including Diuretic</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<criteria>Inclusion criterion : Diagnosis hypertension MSSBP â‰¥ 140 mmHg &lt; 180 mmHg Stable threedrug regimen ( include diuretic ) least 4 week treatment resistant hypertension Male female patient 18 75 year age Exclusion criterion : Recent history MI , heart failure , unstable angina , coronary artery bypass graft , percutaneous coronary intervention , hypertensive encephalopathy , cerebrovascular accident , transient ischemic attack Clinically significant ECG finding related cardiac conduction defect Type 1 diabetes uncontrolled type 2 diabetes ( HbA1c &gt; 9 % ) Malignancies within last 5 year ( exclude basal cell skin cancer ) Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Blood Pressure</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Resistant Hypertension</keyword>
</DOC>